mirtazapine has been researched along with Liver Cirrhosis in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Depression is prevalent in primary biliary cholangitis (PBC) patients." | 1.48 | The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. ( Almishri, W; Frolkis, AD; Kaplan, GG; Patten, S; Shaheen, AA; Swain, MG; Vallerand, I, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaheen, AA | 1 |
| Kaplan, GG | 1 |
| Almishri, W | 1 |
| Vallerand, I | 1 |
| Frolkis, AD | 1 |
| Patten, S | 1 |
| Swain, MG | 1 |
| Hui, CK | 1 |
| Yuen, MF | 1 |
| Wong, WM | 1 |
| Lam, SK | 1 |
| Lai, CL | 1 |
2 other studies available for mirtazapine and Liver Cirrhosis
| Article | Year |
|---|---|
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
Topics: Aged; Antidepressive Agents; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Cohort Studies; D | 2018 |
Mirtazapine-induced hepatotoxicity.
Topics: Antidepressive Agents, Tricyclic; Female; Humans; Liver Cirrhosis; Liver Function Tests; Mianserin; | 2002 |